semaglutide 2.0 Oral Shows Promise in Adolescents with Type 2 Diabetes Ozempic (Semaglutide Injection) 2 mg

Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg for 4 weeks, then increased in 2.5 mg increments to a target dose of 5-15 mg based on glycemic control and tolerability

In major clinical trials, tirzepatide demonstrated a higher efficacy, with patients achieving up to a 22.5% average reduction in body weight

Drive, Suite 215 Boca Raton, FL 27511

We serve patients from Scottsdale AZ, Tempe AZ, Mesa AZ, Paradise Valley AZ, Chandler AZ, Phoenix AZ and BEYOND

Critical difference: Compounded semaglutide does not undergo the same extensive stability testing as FDA-approved products

Enhanced Satiety Youll feel fuller for longer, making it easier to reduce your overall caloric intake